PROMETHEUS BIOSCIENCES, INC. Deferred Revenue
PROMETHEUS BIOSCIENCES, INC. had Deferred Revenue of $1.15 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-05-09
- 2023-03-31: Deferred Revenue, Current $1.15M.
- 2022-12-31: Deferred Revenue, Current $1.30M.
- 2022-09-30: Deferred Revenue, Current $1.54M.
- 2022-06-30: Deferred Revenue, Current $1.78M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2023-03-31 | $1.15M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.30M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $1.54M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.78M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.13M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.67M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.56M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.69M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.42M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.88M 10-K · filed 2022-03-09 |